Intracellular immunization by hammerhead ribozyme against HCV

World Chinese Journal of Digestology

Volumn 11, Issue 2, 2003, Pages 148-150

  Jia, Zhan Sheng ^a   Chen, Lin ^a   Hao, Chun Qiu ^a   Feng, Zhi Hua ^a   Li, Jin Ge ^a   Wang, Jiu Ping ^a   Cao, Yi Zhan ^a   Zhou, Yong Xing ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; RIBOZYME;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; FUSION GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNIZATION; NONHUMAN;

EID: 0037319268     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v11.i2.148     Document Type: Article

References (27)

1. Alt M, Eisenhardt S, Serwe M, Renz R, Engels JW, Caselmann WH. Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation. Eur J Clin Invest 1999;29:868-876
2. Pybus CG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH. The epidemic behavior of the hepatitis C virus. Science 2001;292:2323-2325
3. Rosenberg S. Recent advances in the molecular biology of hepatitis C virus. J Mol Biol 2001;313:451-464
4. Drazan KE. Molecular biology of hepatitis C infection. Liver Transpl 2000;6:396-406
5. Cornberg M, Wedemeyer H, Manns MP. Hepatitis C: therapeutic perspectives. Forum 2001;11:154-162
6. Schmitz V, Qian C, Ruiz J, Sangro B, Melero I, Mazzolini G, Narvaiza I, Prieto J. Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies. Gut 2002;50:130-135
7. Ni YH. In vivo hepatic gene therapy. Acta Paediatr Taiwan 2001;42:191-200
8. Feng Y, Kong YY, Wang Y, Qi GR. Inhibition of hepatitis B virus by hammerhead ribozyme targeted to the poly(A) signal sequence in cultured cells. Biol Chem 2001;382:655-660
9. Macejak DG, Jensen KL, Jamison SF. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 2000;31:769-776
10. Jia ZS, Zhou YX, Lian JQ, Feng ZH, Li GY, Zhang WB. Computer design of the hammerhead ribozyme against hepatitis C virus. Shijie Huaren Xiaohua Zazhi 1999;7:300-302
11. Wen SJ, Xiang KJ, Huang ZH, Zhou R, Qi XZ. Construction of HBV-specific ribozyme and its recombinant with HDV and their cleavage activity in vitro. World J Gastroenterol 2000;6:377-380
12. Song YH, Lin JS, Liu NZ, Kong XJ, Xie N, Wang NX, Jin YX, Liang KH. Anti-HBV hairpin ribozyme-mediated cleavage of target RNA in vitro. World J Gastroenterol 2002;8:91-94
13. Lee PA, Blatt LM, Blanchard KS, Bouhana KS, Pavco PA, Bellon L, Sandberg JA. Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice[J]. Hepatology 2000;32:640-646
14. Jia ZS, Zhou YX, Lian JQ, Feng ZH, Li GY. Inhihation of the expression of hepatitis C virus by hammerhead ribozyme in HHCC. Cell line[J]. Zhonghua Yixue Zazhi 1999;79:631-633
15. Jia ZS, Zhou YX, Feng ZH, Lian JQ, Li GY, Jiao CS, Li GY. Intracellar inhibation of viral gene expression by ribozyme against 5′-noncoding region of hepatitis C virus. Zhonghua Chuanranbing Zazhi 2000;18:10-12
16. Yamamoto M, Hayashi N, Takehara T, Ueda K, Mita E, Tatsumi T, Sasaki Y, Kasahara A, Hori M. Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells. Hepatology 1999;30: 300-307
17. zu Putlitz J, Skerra A, Wands JR. Intracellular expression of a cloned antibody fragment interferes with hepatitiB virus surface antigen secretion. Biochem Biophys Res Commun 1999;255:110-113
18. Chen L, Li G, Tang L, Wang J, Ge XR. The inhibition of lung cancer cell growth by intracellular immunization with LC-1 ScFv. Cell Res 2002;12:47-54
19. Oka Y, Akbar SM, Horiike N, Joko K, Onji M. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology 2001;103:90-97
20. Li JG, Zhou YX, Lian JQ, Jia ZS, Feng ZH. Inhibation of E antigen of hepatitis B virus by ribozyme in HHCC cell lines. Shijie Huaren Xiaohua Zazhi 1999;7:28-30
21. Pertl U, Luster AD, Varki NM, Homann D, Gaedicke G, Reisfeld RA, Lode HN. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J Immunol 2001;166:6944-6951
22. Fraisier C, Irvine A, Wrighton C, Craig R, Dzierzak E. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector. Gene Ther 1998;5:1665-1676
23. Teixeira R, Papatheodoridis GV, Burroughs AK. Management of recurrent hepatitis C after liver transplantation. J Viral Hepat 2001;8:159-168
24. Macejak DG, Jensen KL, Pavco PA, Phipps KM, Heinz BA, Colacino JM, Blatt LM. Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA. J Viral Hepat 2001;8:400-405
25. Lee PA, Blatt LM, Blanchard KS, Bouhana KS, Pavco PA, Bellon L, Sandberg JA. Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice. Hepatology 2000;32:640-646
26. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A. Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease. Science 2000;288:669-672
27. Schmitz V, Qian C, Ruiz J, Sangro B, Melero I, Mazzolini G, Narvaiza I, Prieto J. Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies. Gut 2002;50:130-135